FDA clears Kallisio’s 3D-printed oral insert for radiation therapy
Kallisio recently announced that the FDA has cleared its 3D-printed Stentra, used to protect head and neck cancer patient’s healthy tissue during radiation therapy.
Kallisio recently announced that the FDA has cleared its 3D-printed Stentra, used to protect head and neck cancer patient’s healthy tissue during radiation therapy.
Thirona announced today that it received FDA 510(k) clearance for the latest update of its AI-based LunQ clinical software.
Pi-Cardia announced today that the FDA granted breakthrough device designation for its ShortCut leaflet modification device.